{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:13:20Z","timestamp":1761959600850,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":292,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.lrr.2023.100392","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T22:46:14Z","timestamp":1698446774000},"page":"100392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-8186","authenticated-orcid":false,"given":"Hasna","family":"Hamdaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badreddine","family":"Nouadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumaima","family":"Benlarroubia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiza","family":"Chbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaimaa","family":"Saadoune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fa\u00efza","family":"Bennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf","family":"Lamzouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Chegdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lrr.2023.100392_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-4608(99)00009-6","article-title":"Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in Myeloma","volume":"113","author":"Rajkumar","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.lrr.2023.100392_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/S0968-6053(05)80022-5","article-title":"Diagnostic morphology in multiple myeloma","author":"Bartl","year":"1995","journal-title":"Curr. Diagn. Pathol."},{"key":"10.1016\/j.lrr.2023.100392_bib0003","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cancergen.2020.01.001","article-title":"The combination of WGS and RNA-Seq is superior to conventional diagnostic tests in multiple myeloma: ready for prime time?","volume":"242","author":"H\u00f6llein","year":"2020","journal-title":"Perspectives Cancer Genet."},{"issue":"1","key":"10.1016\/j.lrr.2023.100392_bib0004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/leu.2008.291","article-title":"Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma","volume":"23","author":"Kyle","year":"2009","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.lrr.2023.100392_bib0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/leu.2012.282","article-title":"International myeloma working group. combining fluorescent in situ hybridization data with iss staging improves risk assessment in myeloma: an international myeloma working group collaborative project","volume":"27","author":"Avet-Loiseau","year":"2013","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.lrr.2023.100392_bib0006","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jcp.2007.049585","article-title":"Genomic aberrations and immunohistochemical markers as prognostic indicators in multiple myeloma","volume":"61","author":"Yeung","year":"2008","journal-title":"J. Clin. Pathol."},{"issue":"33","key":"10.1016\/j.lrr.2023.100392_bib0007","doi-asserted-by":"crossref","first-page":"34276","DOI":"10.18632\/oncotarget.5371","article-title":"Detection of recurrent cytogenetic aberrations in multiple myeloma: a comparison between MLPA and iFISH","volume":"6","author":"Zang","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.lrr.2023.100392_bib0008","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2402797","article-title":"Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma","volume":"17","author":"Debes-Marun","year":"2003","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.lrr.2023.100392_bib0009","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1182\/blood-2002-03-0749","article-title":"Intergroupe Francophone du My\u00e9lome. Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy","volume":"100","author":"Moreau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2023.100392_bib0010","doi-asserted-by":"crossref","first-page":"e1363","DOI":"10.1002\/mgg3.1363","article-title":"Cytogenetic and FISH analysis of 93 multiple myeloma Moroccan patients","author":"Hamdaoui","year":"2020","journal-title":"Mol. Genet. Genomic Med."},{"issue":"2","key":"10.1016\/j.lrr.2023.100392_bib0011","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bjhh.2016.01.005","article-title":"Pereira Velloso EDR. Validation of interphase fluorescence in situ hybridization (iFISH) for multiple myeloma using CD138 positive cells","volume":"38","author":"Kishimoto","year":"2016","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"3","key":"10.1016\/j.lrr.2023.100392_bib0012","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lrr.2023.100392_bib0013","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2002-10-3017","article-title":"Clinical and biologic implications of recurrent genomic aberrations in myeloma","volume":"101","author":"Fonseca","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2023.100392_bib0014","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1038\/ncomms7997","article-title":"APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma","volume":"6","author":"Walker","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lrr.2023.100392_bib0015","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1182\/blood-2016-01-631200","article-title":"Treatment of multiple myeloma with high-risk cytogenetics: a consensus of the international myeloma working group","volume":"127","author":"Sonneveld","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2023.100392_bib0016","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/leu.2013.293","article-title":"International myeloma working group recommendations for global myeloma care","volume":"28","author":"Ludwig","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.lrr.2023.100392_bib0017","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","article-title":"Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du My\u00e9lome","volume":"109","author":"Avet-Loiseau","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.lrr.2023.100392_bib0018","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1158\/1078-0432.CCR-10-1843","article-title":"Genomics in multiple myeloma","volume":"17","author":"Munshi","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.lrr.2023.100392_bib0019","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","article-title":"A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1","volume":"109","author":"Shaughnessy","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.lrr.2023.100392_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ijlh.12882","article-title":"Recent advances in cytogenetic characterization of multiple myeloma","volume":"41","author":"Saxe","year":"2019","journal-title":"Int. J. Lab. Hematol."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048923000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048923000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:09:07Z","timestamp":1761959347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048923000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":20,"alternative-id":["S2213048923000328"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2023.100392","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetic abnormalities correlate with clinico-biological characteristics in 30 Moroccan multiple myeloma patients","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2023.100392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100392"}}